Press Releases

GI Dynamics Announces Departure of Chief Commercial Officer

Company Provides Preliminary Update on Second Quarter Revenues LEXINGTON, MA, United States and SYDNEY, Australia – 1 JULY 2014 – GI Dynamics, Inc. (ASX: GID), a medical device company developing innovative treatments for type 2 diabetes and obesity, announced that Mark C. Twyman is leaving his...

read more

Data Presented at ADA Show the Effects of GI Dynamics’ EndoBarrier® Therapy on Glycemic Control and Reducing Diabetes Medication in Patients with Type 2 Diabetes and Obesity

Data Presented at the Scientific Sessions of the American Diabetes Association Demonstrate Increased Bile Acids Levels Following EndoBarrier Therapy; Further Establishes Potential Mechanism of Action SAN FRANCISCO, United States and SYDNEY, Australia – 16 June 2014 – GI Dynamics, Inc. (ASX: GID),...

read more
Page 3 of 41234